Could a diabetes drug boost depression treatment in obese patients?

NCT ID NCT06707012

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 31 times

Summary

This study looks at whether adding metformin, a common diabetes medication, to standard antidepressants can improve depression symptoms in obese individuals. Researchers will compare a group taking metformin with a group taking a placebo. The goal is to see if metformin helps reduce depression scores and improve certain health markers.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fazaia Rurh Pfau Medical College

    RECRUITING

    Karachi, Sindh, 75120, Pakistan

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

  • Fazaia Ruth Pfau Medical College

    RECRUITING

    Karachi, Sindh, 75120, Pakistan

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.